Alaunos Therapeutics Inc (TCRT) is a Healthcare · Biotechnology company listed on NASDAQ. Price $1.28 (-20.00%), Market cap $0.01B, 52-week low–high $1.77 ~ $5.13.
Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. It develops non-hormonal, non-incretin approach, and unlike hormone-based treatments, such as GLP-1 drugs. The company also develops hunTR TCR discovery platform to target driver mutations. Alaunos Therapeutics, Inc. was founded in 2003 and is based in Fort Lauderdale, Florida.
Financial statements, price targets, institutional (13F) holdings and related news for Alaunos Therapeutics Inc are updated in real time on BlackAll Trade.
Alaunos Therapeutics Inc trades at $1.28 (-20.00%). Real-time quotes and charts are available on BlackAll Trade.
Alaunos Therapeutics Inc has a market cap of about $0.01B.
Alaunos Therapeutics, Inc., a pre-clinical stage biopharmaceutical company that develops orally administered small-molecule therapeutics for the treatment of obesity and related metabolic disorders. I